Pronóstico del mercado europeo de diagnóstico de cáncer cerebral hasta 2028: impacto de COVID-19 y análisis regional por tipo de diagnóstico (prueba de imágenes, punción lumbar, biopsia, pruebas moleculares y otros); Tipo de cáncer (neuroma acústico, astrocitoma, craneofaringiomas, ganglioneuromas, glioblastoma multiforme, meningiomas, ependimomas y otros); Usuario final (hospitales, clínicas especializadas, centros de cirugía ambulatoria y otros)

Introducción al mercado

Los cánceres de cerebro se producen debido al crecimiento extracelular de las células del cerebro que causan los tumores. El tumor incluye tumores cerebrales primarios y tumores cerebrales secundarios. Los tumores cerebrales primarios se forman en el cerebro y no se diseminan a otras partes del cuerpo, mientras que los tumores secundarios, también conocidos como metástasis, son aquellos cánceres que comenzaron en otra parte del cuerpo. Los tumores cerebrales se clasifican en 40 tipos principales que a su vez se clasifican en dos grupos principales: benignos, es decir, de crecimiento lento y que tienen menos posibilidades de propagarse, y malignos, es decir, cancerosos y con mayor probabilidad de propagarse.

< p>Por lo tanto, se espera que el aumento en la prevalencia del cáncer de cerebro cree una demanda significativa de diagnóstico de cáncer de cerebro en los próximos años, lo que se prevé que impulse aún más el mercado de diagnóstico de cáncer de cerebro.

Los pacientes con cáncer tienen se ha visto afectado negativamente durante la pandemia de COVID-19, ya que muchas de estas personas pueden estar inmunodeprimidas y ser de mayor edad. Además, las citas de seguimiento del cáncer o de imágenes se han retrasado en muchas clínicas de todo el mundo. El aplazamiento de los exámenes de detección de rutina provocará retrasos en los nuevos diagnósticos de cáncer. Las clínicas continúan monitoreando y adaptando sus horarios de citas en función de los brotes locales de COVID-19. Los estudios sobre la COVID-19 en pacientes con cáncer son limitados, pero indican consistentemente que esta población corre riesgo de sufrir una enfermedad más grave por la COVID-19. Los datos de estudios recientes también sugieren que los pacientes pediátricos con cáncer tienen un menor riesgo de sufrir una enfermedad grave por COVID-19 en comparación con los adultos. Ciertas características de la infección por SARS-CoV-2 detectadas mediante imágenes pulmonares, cerebrales y gastrointestinales pueden confundir a los radiólogos. Interpretación del diagnóstico, estadificación y respuesta al tratamiento del cáncer. Por último, a medida que las clínicas comienzan a reabrir para citas de rutina, se han implementado protocolos para reducir la exposición de los pacientes al SARS-CoV-2 durante sus visitas. Esta revisión detalla diferentes perspectivas sobre el impacto de la pandemia de COVID-19 en los pacientes con cáncer y en las imágenes del cáncer.

Descripción general y dinámica del mercado

Se espera que el mercado de diagnóstico del cáncer de cerebro en Europa crezca de 207,5 millones de dólares en 2021 a 601,0 dólares estadounidenses millones para 2028; se estima que crecerá a una tasa compuesta anual del 16,4% de 2021 a 2028. La inteligencia artificial implica el uso de potentes computadoras para realizar tareas generalmente asociadas con la inteligencia humana. Un tipo de inteligencia artificial llamado aprendizaje profundo utiliza algoritmos matemáticos complejos (a veces llamados redes neuronales convolucionales) para extraer características de los datos y luego \"entrenarlas\". Esta formación permite al algoritmo reconocer patrones y realizar tareas como analizar imágenes. Para combinar las poderosas funciones del generador de imágenes SRH con la IA, los investigadores comenzaron a realizar entrenamiento de algoritmos en las imágenes de tejido tumoral cerebral producidas por el SRH. Los investigadores señalaron que la capacidad de la tecnología de inteligencia artificial y los patólogos para verificarse entre sí resalta la necesidad de que los patólogos cooperen con la tecnología de inteligencia artificial para interpretar casos desafiantes y garantizar la mayor precisión diagnóstica posible. Tanto la SRH como las imágenes de IA son tecnologías emergentes, por lo que integrarlas en la atención médica será un desafío. La tecnología de inteligencia artificial permite a los cirujanos identificar áreas que contienen tumores o tejido sano de manera rápida y precisa. Por lo tanto, la inteligencia artificial SRH se utiliza cada vez más para mejorar el diagnóstico de tumores cerebrales durante la cirugía.

Segmentos de mercado clave

En términos de tipo de diagnóstico, el segmento de pruebas de imágenes representó la mayor participación del mercado europeo de diagnóstico de cáncer cerebral en 2020. En términos de tipo de cáncer, el segmento de glioblastoma multiforme representó la mayor participación del mercado europeo de diagnóstico de cáncer cerebral en 2020. En términos de usuario final, el segmento de hospitales representó la mayor parte del mercado europeo de diagnóstico de cáncer cerebral en 2020.

Principales fuentes y empresas enumeradas

Algunas de las principales fuentes primarias y secundarias a las que se hace referencia para preparar este informe sobre el mercado de diagnóstico del cáncer cerebral en Europa son sitios web de empresas, publicaciones anuales. informes, informes financieros, documentos del gobierno nacional y base de datos estadísticos, entre otros. Las principales empresas que figuran en el informe son Thermo Fisher Scientific Inc., Siemens Healthineers A, GE Healthcare, Biocept, Inc., Koninklijke Philips NV, Canon Medical Systems, Hitachi, Ltd. y Neusoft Medical Systems.

Razones Comprar informe

Comprender el panorama del mercado europeo de diagnóstico de cáncer cerebral e identificar los segmentos del mercado que tienen más probabilidades de garantizar una sólida retorno
Manténgase a la vanguardia al comprender el panorama competitivo en constante cambio para el mercado europeo de diagnóstico de cáncer de cerebro
Planifique de manera eficiente fusiones y adquisiciones y acuerdos de asociación en el mercado europeo de diagnóstico de cáncer de cerebro identificando segmentos de mercado con las ventas probables más prometedoras
Ayuda a tomar decisiones comerciales informadas a partir de un análisis perspicaz y completo del desempeño del mercado de varios segmentos del mercado europeo de diagnóstico de cáncer de cerebro
Obtener pronóstico de ingresos de mercado para mercado por varios segmentos entre 2021 y 2028 en la región de Europa.

Europa Segmentación del mercado de diagnóstico de cáncer de cerebro

Por tipo de diagnóstico

Prueba de imágenes
- Resonancia magnética
- Tomografía computarizada
- PET
Biopsia
Pruebas moleculares
Punción lumbar
Otros

Por tipo de cáncer

Glioblastoma Multiforme
Astrocitomas
Ependimomas
Otros

Por Usuario final

Hospitales
Clínicas especializadas
Centros de Cirugía Ambulatoria
Otros

Por País

Europa
- Alemania
- Reino Unido
- Francia
- España
- Italia
- Resto de Europa

< strong>Empresas mencionadas

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Brain Cancer Diagnostics Market – By Diagnostic Type

1.3.2 Brain Cancer Diagnostics Market – By Cancer Type

1.3.3 Brain Cancer Diagnostics Market – By End User

1.3.4 Europe Brain Cancer Diagnostics Market – By Country

2. Europe Brain Cancer Diagnostics Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Brain Cancer Diagnostics Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Brain Cancer Diagnostics Market- Europe PEST Analysis

4.3 Expert Opinion

5. Europe Brain Cancer Diagnostics Market - Key Market Dynamics

5.1 Market Drivers

5.1.1 Increase in Prevalence of Brain Cancer

5.1.2 Rise in Number of Cigarette Smokers

5.2 Market Restraints

5.2.1 High Cost of Diagnosis

5.3 Future Trends

5.3.1 Use of Stimulated Raman Histology (SRH)?Artificial Intelligence (AI) to Enhance Brain Tumor Diagnosis During Surgery

5.4 Impact Analysis

6. Brain Cancer Diagnostics Market – Europe Analysis

6.1 Europe Brain Cancer Diagnostics Market Revenue Forecasts and Analysis

7. Europe Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Diagnostic Type

7.1 Overview

7.2 Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)

7.3 Imaging Tests

7.3.1 Overview

7.3.2 Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3 MRI

7.3.3.1 Overview

7.3.3.2 MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4 CT Scan

7.3.4.1 Overview

7.3.4.2 CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.5 Positron emission tomography (PET)

7.3.5.1 Overview

7.3.5.2 Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Lumbar Puncture

7.4.1 Overview

7.4.2 Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Biopsy

7.5.1 Overview

7.5.2 Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.6 Molecular Testing

7.6.1 Overview

7.6.2 Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.7 Others

7.7.1 Overview

7.7.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8. Europe Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Cancer Type

8.1 Overview

8.2 Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)

8.3 Astrocytomas

8.3.1 Overview

8.3.2 Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Glioblastoma Multiforme

8.4.1 Overview

8.4.2 Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Ependymomas

8.5.1 Overview

8.5.2 Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. Brain Cancer Diagnostics Market Analysis – By End user

9.1 Overview

9.2 Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Specialty Clinics

9.4.1 Overview

9.4.2 Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Ambulatory Surgical Centers

9.5.1 Overview

9.5.2 Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10. Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 – Geographical Analysis

10.1 Europe: Brain Cancer Diagnostics Market Revenue and Forecasts to 2028

10.1.1 Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Country (%)

10.1.2 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.1 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.2 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

10.1.2.2.1 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

10.1.2.3 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

10.1.2.4 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.3 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.3.1 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.3.2 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

10.1.3.2.1 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

10.1.3.3 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

10.1.3.4 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.4 France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.4.1 France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.4.2 France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

10.1.4.2.1 France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

10.1.4.3 France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

10.1.4.4 France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.5 Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.5.1 Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.5.2 Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

10.1.5.2.1 Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

10.1.5.3 Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

10.1.5.4 Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.6 Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.6.1 Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.6.2 Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

10.1.6.2.1 Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

10.1.6.3 Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

10.1.6.4 Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.7 Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.7.1 Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.7.2 Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

10.1.7.2.1 Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

10.1.7.3 Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

10.1.7.4 Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

11. Impact Of COVID-19 Pandemic on Europe Brain Cancer Diagnostics Market

11.1 Europe: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Growth Strategies Done by the Companies in the Market, (%)

12.1 Organic Developments

12.1.1 Overview

12.2 Inorganic Developments

12.2.1 Overview

13. Company Profiles

13.1 THERMO FISHER SCIENTIFIC INC.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Siemens Healthineers AG

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 GE Healthcare

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Biocept, Inc.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Koninklijke Philips N.V.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Canon Medical Systems

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Hitachi, Ltd.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Neusoft Medical Systems

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

14. Appendix

14.1 About the Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type US$ Mn)

Table 2. UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test US$ Mn)

Table 3. UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type US$ Mn)

Table 4. UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User US$ Mn)

Table 5. Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

Table 6. Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

Table 7. Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type US$ Mn)

Table 8. Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User US$ Mn)

Table 9. France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

Table 10. France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

Table 11. France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

Table 12. France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

Table 13. Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

Table 14. Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

Table 15. Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

Table 16. Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

Table 17. Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

Table 18. Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

Table 19. Spain Brain Cancer Diagnostics Market Revenue and Forecast to 2028, by Cancer Type (USD Million)

Table 20. Spain Brain Cancer Diagnostics Market Revenue and Forecast to 2028, by End User (USD Million)

Table 21. Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

Table 22. Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

Table 23. Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

Table 24. Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

Table 25. Organic Developments in the Brain Cancer Diagnostics Market

Table 26. Inorganic Developments in the Brain Cancer Diagnostics Market

Table 27. Glossary of Terms, Brain Cancer Diagnostics Market

LIST OF FIGURES

Figure 1. Brain Cancer Diagnostics Market Segmentation

Figure 2. Europe Brain Cancer Diagnostics Market Overview

Figure 3. Imaging Test Segment Held Largest Share of Diagnostic Type in Brain Cancer Diagnostics Market

Figure 4. Germany is Expected to Show Remarkable Growth During the Forecast Period

Figure 5. Brain Cancer Diagnostics Market - Europe PEST Analysis

Figure 6. Brain Cancer Diagnostics Market Impact Analysis of Driver and Restraints

Figure 7. Europe Brain cancer diagnostics Market – Revenue Forecasts and Analysis – 2020- 2028

Figure 8. Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)

Figure 9. Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10. MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11. CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)

Figure 18. Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)

Figure 23. Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. Europe: Brain Cancer Diagnostics Market Revenue Overview, by Country, 2021 (US$ MN)

Figure 28. Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Country (%)

Figure 29. UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 30. Germany Brain Cancer Diagnostics Products Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 31. France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 32. Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 33. Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 34. Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 35. Impact of COVID-19 Pandemic in European Country Markets

Figure 36. Growth Strategies Done by the Companies in the Market, (%)

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe brain cancer diagnostics market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe brain cancer diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the brain cancer diagnostics market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv..	May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P..	May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample